TR199700723T1 - Uyu�turucu (ila�) ba��ml�l���ndan zarar g�ren hastalar�n tedavisi i�in melatonin kullan�m�. - Google Patents
Uyu�turucu (ila�) ba��ml�l���ndan zarar g�ren hastalar�n tedavisi i�in melatonin kullan�m�.Info
- Publication number
- TR199700723T1 TR199700723T1 TR97/00723T TR9700723T TR199700723T1 TR 199700723 T1 TR199700723 T1 TR 199700723T1 TR 97/00723 T TR97/00723 T TR 97/00723T TR 9700723 T TR9700723 T TR 9700723T TR 199700723 T1 TR199700723 T1 TR 199700723T1
- Authority
- TR
- Turkey
- Prior art keywords
- drug
- melatonin
- treatment
- addiction
- diagnosed
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Toxicology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Anesthesiology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/381,535 US6469044B1 (en) | 1995-02-01 | 1995-02-01 | Method for treating patients suffering from drug dependencies which lead to plasma melationin deficiencies |
EP95303853A EP0724878B1 (en) | 1995-02-01 | 1995-06-06 | Use of melatonin for treating patients suffering from drug dependencies |
Publications (1)
Publication Number | Publication Date |
---|---|
TR199700723T1 true TR199700723T1 (xx) | 1998-02-21 |
Family
ID=26140195
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR97/00723T TR199700723T1 (xx) | 1995-02-01 | 1996-01-29 | Uyu�turucu (ila�) ba��ml�l���ndan zarar g�ren hastalar�n tedavisi i�in melatonin kullan�m�. |
Country Status (22)
Country | Link |
---|---|
JP (1) | JP4516159B2 (no) |
CN (1) | CN1083263C (no) |
AT (1) | AT408188B (no) |
AU (1) | AU695366B2 (no) |
BG (1) | BG62876B1 (no) |
BR (1) | BR9607169A (no) |
CZ (1) | CZ291349B6 (no) |
DK (1) | DK176081B1 (no) |
EE (1) | EE03384B1 (no) |
FI (1) | FI119586B (no) |
IS (1) | IS1980B (no) |
LU (1) | LU90118B1 (no) |
LV (1) | LV11940B (no) |
MD (1) | MD1716C2 (no) |
NO (1) | NO312814B1 (no) |
NZ (1) | NZ298878A (no) |
PL (1) | PL183148B1 (no) |
SI (1) | SI9620022A (no) |
SK (1) | SK284521B6 (no) |
TR (1) | TR199700723T1 (no) |
TW (1) | TW483757B (no) |
WO (1) | WO1996023496A1 (no) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60034373T2 (de) | 2000-01-05 | 2007-12-20 | Neurim Pharmaceuticals (1991) Ltd. | Methode und zusammensetzung zur behandlung von resistenz gegen antihypertensiva und verwandten zuständen |
IL149377A (en) * | 2002-04-28 | 2012-10-31 | Neurim Pharma 1991 | Pharmaceutical formulation comprising melatonin for the potentiation of the effect of hypnotic compounds |
IL155666A (en) | 2003-04-29 | 2013-12-31 | Neurim Pharma 1991 | Insomnia treatment |
US9119846B2 (en) | 2003-04-29 | 2015-09-01 | Neurim Pharmaceuticals (1991) Ltd. | Method and composition for enhancing cognition in alzheimer's patients |
US11918557B2 (en) | 2012-01-26 | 2024-03-05 | Vanda Pharmaceuticals Inc. | Treatment of circadian rhythm disorders |
BR112014018429A8 (pt) | 2012-01-26 | 2017-07-11 | Vanda Pharmaceuticals Inc | Método para tratar um paciente que sofre de não-24, e, método para o tratamento crônico de não-24 em uma pessoa que está totalmente cega |
AU2013361459A1 (en) | 2012-12-18 | 2015-07-02 | Vanda Pharmaceuticals Inc. | Treatment of circadian rhythm disorders |
US11090285B2 (en) | 2013-11-12 | 2021-08-17 | Vanda Pharmaceuticals Inc | Treatment of circadian rhythm disorders |
US10376487B2 (en) | 2013-11-12 | 2019-08-13 | Vanda Pharmaceuticals Inc. | Method of treatment |
JP6830156B2 (ja) * | 2016-10-31 | 2021-02-17 | ニューリム・ファーマシューティカルズ・リミテッドNeurim Pharmaceuticals Ltd. | メラトニンミニタブレットおよびその製造方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69229490T2 (de) * | 1991-05-09 | 2000-02-17 | Neurim Pharmaceuticals (1991) Ltd., Tel Aviv | Melatonin enthaltende Arzneimittel |
IT1251544B (it) * | 1991-05-13 | 1995-05-17 | Gabriele Biella | Composizioni farmaceutiche attive nella terapia dei disturbi del sonno comprendenti melatonina o un suo derivato in associazione con un derivato benzodiazepinico |
-
1996
- 1996-01-29 TR TR97/00723T patent/TR199700723T1/xx unknown
- 1996-01-29 SI SI9620022A patent/SI9620022A/sl not_active IP Right Cessation
- 1996-01-29 AT AT0901396A patent/AT408188B/de not_active IP Right Cessation
- 1996-01-29 WO PCT/IB1996/000082 patent/WO1996023496A1/en active IP Right Grant
- 1996-01-29 NZ NZ298878A patent/NZ298878A/xx not_active IP Right Cessation
- 1996-01-29 MD MD97-0254A patent/MD1716C2/ro not_active IP Right Cessation
- 1996-01-29 BR BR9607169A patent/BR9607169A/pt not_active Application Discontinuation
- 1996-01-29 CN CN96191750A patent/CN1083263C/zh not_active Expired - Lifetime
- 1996-01-29 EE EE9700166A patent/EE03384B1/xx not_active IP Right Cessation
- 1996-01-29 JP JP52338596A patent/JP4516159B2/ja not_active Expired - Lifetime
- 1996-01-29 SK SK1030-97A patent/SK284521B6/sk unknown
- 1996-01-29 PL PL96321630A patent/PL183148B1/pl unknown
- 1996-01-29 CZ CZ19972405A patent/CZ291349B6/cs not_active IP Right Cessation
- 1996-01-29 AU AU44574/96A patent/AU695366B2/en not_active Expired
- 1996-04-12 TW TW085104319A patent/TW483757B/zh not_active IP Right Cessation
-
1997
- 1997-07-24 LV LVP-97-144A patent/LV11940B/en unknown
- 1997-07-25 IS IS4532A patent/IS1980B/is unknown
- 1997-07-30 DK DK199700896A patent/DK176081B1/da not_active IP Right Cessation
- 1997-07-30 BG BG101803A patent/BG62876B1/bg unknown
- 1997-07-31 FI FI973185A patent/FI119586B/fi not_active IP Right Cessation
- 1997-07-31 NO NO19973531A patent/NO312814B1/no not_active IP Right Cessation
- 1997-08-01 LU LU90118A patent/LU90118B1/fr active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MEYER et al. | Optimizing metoclopramide control of cisplatin-induced emesis | |
Power et al. | Controlled study of withdrawal symptoms and rebound anxiety after six week course of diazepam for generalised anxiety. | |
McMillan et al. | Outcome of renal replacement treatment in patients with diabetes mellitus. | |
EP1019072A4 (en) | ASSISTANCE PROCESS FOR DIFFERENTIAL DIAGNOSIS AND TREATMENT OF AUTISM SYNDROME | |
TR199900413T2 (xx) | �laca diren�li streptokoklar�n neden oldu�u pn�moni (pn�mokok) tedavisi i�in bir ila� yap�m�nda bir amoksisilin ve klavulanat kombinasyonunun kullan�m�. | |
DE69804974D1 (de) | Opioid-konjugate mit endogenen trägerproteinen | |
TR199700723T1 (xx) | Uyu�turucu (ila�) ba��ml�l���ndan zarar g�ren hastalar�n tedavisi i�in melatonin kullan�m�. | |
Finland et al. | Oral penicillin | |
Dressman et al. | Absorption of flurbiprofen in the fed and fasted states | |
ES2139842T3 (es) | Uso de la melatonina para tratar a pacientes que sufren drogodependencia. | |
Pier et al. | Chronic graft versus host disease presenting with polymyositis. | |
WALLIN et al. | Cimetidine and effect of warfarin | |
NZ284914A (en) | use of anti-arthritogenic peptide antibodies, nonadsorbable antibiotic or benign bacteria to treat rheumatoid arthritis by enteral administration | |
AL-KAWAS et al. | Cimetidine and agranulocytosis | |
Mascioli et al. | Characteristics of participants at baseline in the Treatment of Mild Hypertension Study (TOMHS) | |
LUK et al. | Cimetidine and impaired renal function | |
Abate et al. | Effect of naproxen and sulindac on blood pressure response to atenolol | |
Lawson et al. | Amoxycillin: Pharmacokinetic studies in normal subjects, patients with pernicious anaemia and those with renal failure | |
SlNKOVICS et al. | Eikenella corrodens as pathogen | |
KR950703958A (ko) | Hiv 감염증을 치료하기 위한,다른 비뉴클레오사이드 역 전사효소 억제제와 혼합된 bhap 화합물의 용도(use of bhap compounds in combination with other non-nucleoside reverse transcriptase inhibitors for the treatment of hiv infection) | |
GAROFALO et al. | Zinc deficiency and intestinal bypass procedures | |
Davies et al. | Fenclofenac in osteoarthrosis | |
Hughes | Deficiency Patterns in Metallic Poisoning | |
Gallant | Antidepressant overdose: symptoms and treatment | |
REIMER et al. | Acute nonlymphocytic leukemia |